Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
Sell
44
PLX Quote, Financials, Valuation and Earnings
Last price:
$2.33
Seasonality move
:
1.71%
Day range:
$2.37 - $2.65
52-week range:
$0.82 - $2.76
Dividend yield:
0%
P/E ratio:
121.00x
P/S ratio:
4.21x
P/B ratio:
5.56x
Volume:
2M
Avg. volume:
739.5K
1-year change:
84.21%
Market cap:
$180.4M
Revenue:
$65.5M
EPS (TTM):
-$0.16
Protalix BioTherapeutics Number of Institutional Trades
Protalix BioTherapeutics Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$17.1M
(Last 6 Months)
Current Institutional Ownership Percentage
7.36%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$83.9M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Protalix BioTherapeutics Institutional Ownership
-
What Percentage Of PLX Is Owned by Institutions?
7.36% of PLX is owned by institutions.
-
How Many Institutions Own PLX Shares?
Protalix BioTherapeutics stock is owned by 139 institutional shareholders at this time.
-
Have Institutions Been Buying PLX Stock?
Yes, institutions have bought 6.1M shares of PLX in the last quarter.
-
Have Institutions Been Selling PLX Stock?
Yes, institutions have sold 27.7M shares of PLX over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Is Ford Stock Undervalued Amid the EV Transition?
There is a lot going on in the electric vehicle…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
